Chemokine Ligand-Receptor Axes for Therapeutic Targeting During Skin Regeneration

Journal Title: Journal of Dermatology Research - Year 2023, Vol 4, Issue 3

Abstract

Chemokines and their cognate receptor interactions regulate the balance between pro-inflammatory and anti-inflammatory signals to support the physiological functions of the skin. Chemokines also regulate the process of angiogenesis, epithelialization and collagen deposition. A severely dysregulated chemokine ligand-receptor network has been observed in chronic non-healing wounds and skin diseases. Evaluation of the chemokine signaling pathways in pathological skin conditions is essential for the development of targeted therapeutic interventions that can enhance skin regeneration. Although chemokines and their receptors serve as attractive targets for drug discovery, clinical trials to date have seen limited success, especially in skin regeneration. Repurposing of the already established drugs can overcome the limitations. Therefore, we identified a set of chemokines and chemokine receptors that are expressed during skin regeneration. Further, we provided a network of existing drugs targeting these chemokines and chemokine receptors that can be repurposed for enhancing skin regeneration in chronic wounds and skin diseases. This review underscores the pivotal role of chemokine ligand-receptors axes in complex wounds and skin diseases and highlights the preclinical and clinical breakthroughs targeting these networks for skin regeneration.

Authors and Affiliations

Subholakshmi Choudhury, Amitava Das

Keywords

Related Articles

Psychodermatoses: Diagnostic and Therapeutic Challenges

A complicated subgroup of psychodermatological conditions is self-induced dermatoses, which affect not only the skin but also its appendages (hair and nails). These conditions occur when people harm themselves due to und...

Treatment-Resistant Melasma Response to Oral Tranexamic Acid

Melasma, a common acquired hyperpigmentation disorder primarily affecting facial skin, poses significant therapeutic challenges due to the limited efficacy and potential side effects of available treatments. Tranexamic A...

Most Common Drug Eruptions by Pattern and Drug Class: A Review

Cutaneous drug reactions come in many different morphologies, distributions and severities ranging from pruritus and erythema to diffuse epidermal denudation requiring hospitalization. The wide variety of presentations a...

Synergistic antiaging and Dermal Restorative Effects of an Oral Bioactive Procollagen and Astaxanthin Supplement with A Topical Retinyl Palmitate, Vitamin C, Hyaluronic Acid and Alpha Hidroxy Acid Based Regimen

Aging is a natural process undergone by every organism, with progressive changes that lead to an impairment of many biological processes. The human skin ages through several mechanisms which may cause changes to the mo...

Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison of a Single Dose of Super-bioavailable Itraconazole 130 mg and Innovator SUBA®-Itraconazole Capsules 130 mg (2 x 65 mg) in Healthy Adults Under Fed Conditions

Introduction: Itraconazole (ITZ), an antifungal agent taken orally, demonstrates intricate and variable absorption kinetics, significantly impacted by food intake. The invention of Super-Bioavailable Itraconazole (SITZ)...

Download PDF file
  • EP ID EP724143
  • DOI https://doi.org/10.46889/JDR.2023.4308
  • Views 50
  • Downloads 0

How To Cite

Subholakshmi Choudhury, Amitava Das (2023). Chemokine Ligand-Receptor Axes for Therapeutic Targeting During Skin Regeneration. Journal of Dermatology Research, 4(3), -. https://europub.co.uk/articles/-A-724143